Contact: Astbury 7.103 / 7.106 / 7.110, +44(0) 113 34 33025,
I am a senior research technician for the BioScreening Technology Group (BSTG), a facility for the development and screening of non-antibody binding proteins. The BSTG has developed libraries based on a small stable scaffold protein called Adhiron, which can be screened against a wide range of target molecules by phage display to identify specific binders. The BSTG has formed collaborative partnerships with academics, clinicians and industry to develop Adhiron technology as reagents for R&D, diagnostics, and therapeutics. We work closely with Avacta Life Sciences where Adhiron technology has been commercialised as Affimer technology.
As well as working full-time, I am also a part-time PhD student (from October 2015). My project is the study of protein-protein interaction (PPI) domains (e.g. SH3 domains) in cell signalling pathways implicated in human cancers.
Previous to my career at the University of Leeds, I have been employed as a research and development scientist in both industry, and academia, and now have more than 10 years’ experience in the fields of bioscience.
Connect with me on LinkedIn: www.linkedin.com/in/anna-tang-69682376
C. Tiede, A. A. S. Tang, S. E. Deacon, U. Mandal, J. E. Nettleship, R. L. Owen, S. E. George, D. J. Harrison, R. J. Owens, D. C. Tomlinson and M. J. McPherson, Protein engineering, design & selection : PEDS, 2014, 27, 145-155.
A. E. Rawlings, J. P. Bramble, A. A. S. Tang, L. A. Somner, A. E. Monnington, D. J. Cooke, M. J. McPherson, D. C. Tomlinson and S. S. Staniland, Chemical Science, 2015, 6, 5586-5594.
E. Koutsoumpeli, C. Tiede‡, J. Murray, A. Tang, R. S. Bon, D. C. Tomlinson, and S. Johnson, Analytical Chemistry, 2017. doi: 10.1021/acs.analchem.6b04790.
R. Sharma, S. E. Deacon, D. Nowak, S. E. George, M. P. Szymonik, A. A. Tang, D. C. Tomlinson, A. G. Davies, M. J. McPherson, C. Wälti, Biosensors and Bioelectronics, 2016, 80, 607-613.